Nu-Med Plus (NUMD) EBIT Growth (5y) (2017 - 2025)
Nu-Med Plus (NUMD) EBIT Growth (5y) (2017 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.88 Bn | 176.59 Bn | 6.27 Bn |
| 2 | Stryker | 128.95 Bn | 126.07 Bn | 3.81 Bn |
| 3 | Medtronic | 108.68 Bn | 99.46 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.54 Bn | 67.09 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.26 Bn | 44.58 Bn | 1.29 Bn |
| 6 | Dexcom | 28.39 Bn | 27.28 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 28.22 Bn | 25.93 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.89 Bn | 26.31 Bn | - |
| 9 | Koninklijke Philips | 24.66 Bn | 21.54 Bn | 2.07 Bn |
| 10 | Nu-Med Plus | 1.67 Mn | 1.67 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 54.59% |
| Sep 30, 2025 | 53.22% |
| Jun 30, 2025 | 59.05% |
| Mar 31, 2025 | 34.35% |
| Dec 31, 2024 | 47.04% |
| Sep 30, 2024 | 34.66% |
| Jun 30, 2024 | 41.97% |
| Mar 31, 2024 | 45.39% |
| Dec 31, 2023 | 30.28% |
| Sep 30, 2023 | 50.74% |
| Jun 30, 2023 | 32.83% |
| Mar 31, 2023 | 28.32% |
| Dec 31, 2022 | 46.64% |
| Sep 30, 2022 | 15.87% |
| Jun 30, 2022 | 12.20% |
| Mar 31, 2022 | 3.07% |
| Dec 31, 2021 | 17.00% |
| Sep 30, 2021 | 29.83% |
| Jun 30, 2021 | -7.20% |
| Mar 31, 2021 | -40.28% |